OrbiMed Announces New General Partner NEW YORK, May 9, 2018 – OrbiMed is pleased to announce the promotion of C. Scotland Stevens to General Partner. Scot joins the firm’s five existing General Partners, Sven H. Borho, Carl L. Gordon, Jonathan T. Silverstein, W. Carter Neild and Geoffrey C. Hsu. Scot joined OrbiMed in 2005 from Goldman, Sachs & Co., and in recent years has led the firm’s trading activities and derivatives investment strategies. Scot has provided strong leadership across the firm, in particular for OrbiMed’s public equity and hedge fund team. The addition of Scot as a General Partner is an expression of OrbiMed's commitment to strengthening the organization for the long term. “Scot is a consummate professional and team leader, elevating those around him.” said Managing Member Sven H. Borho. “We are proud to have him as a new General Partner and leader of the firm.” Scot can be reached at (212) 739-6400 or [email protected]. About OrbiMed OrbiMed is a leading healthcare investment firm, with $14 billion in assets under management. OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, utilizing a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed maintains offices in New York City, San Francisco, Shanghai, Hong Kong, Mumbai and Herzliya. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and global team resources and support to help build world-class healthcare companies. Contact W. Carter Neild, CFA Phone: (212) 739.6400 Email: [email protected] www.OrbiMed.com OrbiMed Advisors LLC. 601 Lexington Avenue, 54th Floor. New York, NY 10022 • Phone: 212.739.6400 • Fax: 212.739.6444 .